Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
151
Period ended Jun 30, 2026
Change on a year earlier
-73.0%
560 in Q2 2025
History
66 quarters
Since Q1 2009
Sources
59
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring Costs ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 151 | -73.0% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 195 | +182.6% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 213 | +317.6% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 47 | -16.1% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 560 | +600.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 69 | -43.9% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 51 | -80.0% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 56 | -55.6% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 80 | -47.0% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 123 | +83.6% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 255 | +420.4% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 126 | +34.0% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 151 | +6.3% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 67 | +26.4% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 49 | -71.8% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 94 | -12.1% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 142 | +73.2% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 53 | -82.2% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 174 | -43.9% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 107 | -5.3% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 82 | 0.0% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 297 | +312.5% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 310 | +70.3% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 113 | -51.3% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 82 | +39.0% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2020 | Mar 31, 2020 | 72 | -52.9% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 182 | +31.9% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 232 | +35.7% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 59 | -74.1% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 153 | +61.1% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 138 | -54.9% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 171 | +11.8% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 228 | +37.3% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 95 | -37.1% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 306 | +15.5% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 153 | -5.0% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 166 | +23.9% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 151 | +65.9% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 265 | +13.7% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 161 | +42.5% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 134 | -29.8% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 91 | +11.0% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 233 | -33.2% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 113 | -69.9% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 191 | +17.2% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 82 | -34.4% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 349 | – | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 376 | -63.3% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 163 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 125 | +5.0% | Form 10-Q (filed 2014-05-08) ↗ |
| Q2 2013 | Sep 30, 2013 | 1,025 | +831.8% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 119 | -45.7% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 191 | -64.2% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 110 | -7.6% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 144 | – | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 219 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 533 | +340.5% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 119 | +138.0% | Form 10-Q (filed 2011-11-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 121 | -91.9% | Form 10-Q (filed 2011-11-08) ↗ |
| Q3 2010 | Sep 30, 2010 | 50 | +17.9% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 526 | +1,306.4% | Form 10-Q (filed 2011-08-08) ↗ |
| Q1 2010 | Mar 31, 2010 | 288 | +347.9% | Form 10-Q (filed 2011-05-09) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,490 | – | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 42.4 | – | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2009 | Jun 30, 2009 | 37.4 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2009 | Mar 31, 2009 | 64.3 | – | Form 10-Q (filed 2010-05-07) ↗ |
Cite this data
StockData. (2026). Merck Restructuring Costs ($M) ($M), quarterly Q1 2009–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_restr
See every metric in the Merck KPI table. Data updated Oct 26, 2026.